| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |